WO2012097368A3 - Amorces et sondes her3 et her4 pour détecter l'expression de l'arnm her3 et her4 - Google Patents

Amorces et sondes her3 et her4 pour détecter l'expression de l'arnm her3 et her4 Download PDF

Info

Publication number
WO2012097368A3
WO2012097368A3 PCT/US2012/021546 US2012021546W WO2012097368A3 WO 2012097368 A3 WO2012097368 A3 WO 2012097368A3 US 2012021546 W US2012021546 W US 2012021546W WO 2012097368 A3 WO2012097368 A3 WO 2012097368A3
Authority
WO
WIPO (PCT)
Prior art keywords
her3
her4
detecting
primers
probes
Prior art date
Application number
PCT/US2012/021546
Other languages
English (en)
Other versions
WO2012097368A2 (fr
Inventor
Craig Stephens
Original Assignee
Response Genetics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Response Genetics, Inc. filed Critical Response Genetics, Inc.
Publication of WO2012097368A2 publication Critical patent/WO2012097368A2/fr
Publication of WO2012097368A3 publication Critical patent/WO2012097368A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Cette invention concerne des procédés, des amorces et des sondes utiles pour détecter la présence de séquences HER1, HER2, HER3 et/ou HER4 ou une combinaison de celles-ci dans un échantillon, plus spécifiquement, pour mesurer leurs niveaux d'expression dans l'échantillon. Cette invention concerne des paires d'amorces oligonucléotidiques et des procédés concernant leur utilisation pour détecter les niveaux d'ARNm HER1, HER2, HER3 et/ou HER4.
PCT/US2012/021546 2011-01-14 2012-01-17 Amorces et sondes her3 et her4 pour détecter l'expression de l'arnm her3 et her4 WO2012097368A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161432933P 2011-01-14 2011-01-14
US61/432,933 2011-01-14

Publications (2)

Publication Number Publication Date
WO2012097368A2 WO2012097368A2 (fr) 2012-07-19
WO2012097368A3 true WO2012097368A3 (fr) 2014-04-10

Family

ID=46507705

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/021546 WO2012097368A2 (fr) 2011-01-14 2012-01-17 Amorces et sondes her3 et her4 pour détecter l'expression de l'arnm her3 et her4

Country Status (1)

Country Link
WO (1) WO2012097368A2 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192652A1 (en) * 2001-06-11 2002-12-19 Danenberg Kathleen D. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US20040157255A1 (en) * 2003-02-06 2004-08-12 David Agus Gene expression markers for response to EGFR inhibitor drugs
US20070065845A1 (en) * 2002-03-13 2007-03-22 Baker Joffre B Gene expression profiling in biopsied tumor tissues
US20080026393A1 (en) * 2006-05-25 2008-01-31 The Board Of Trustees Of The Leland Stanford Junior University Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby
US20100008975A1 (en) * 2007-03-02 2010-01-14 Amler Lukas C Predicting response to a HER inhibitor

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192652A1 (en) * 2001-06-11 2002-12-19 Danenberg Kathleen D. Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
US20070065845A1 (en) * 2002-03-13 2007-03-22 Baker Joffre B Gene expression profiling in biopsied tumor tissues
US20040157255A1 (en) * 2003-02-06 2004-08-12 David Agus Gene expression markers for response to EGFR inhibitor drugs
US20080026393A1 (en) * 2006-05-25 2008-01-31 The Board Of Trustees Of The Leland Stanford Junior University Method to produce single stranded DNA of defined length and sequence and DNA probes produced thereby
US20100008975A1 (en) * 2007-03-02 2010-01-14 Amler Lukas C Predicting response to a HER inhibitor

Also Published As

Publication number Publication date
WO2012097368A2 (fr) 2012-07-19

Similar Documents

Publication Publication Date Title
GB201200658D0 (en) Methods,compositions,and kits for determining the presence/absence of a variant nucleic acid sequence
WO2013022786A3 (fr) Biomarqueurs micro-arn
WO2013033609A3 (fr) Méthodes et compositions pour le traitement et le diagnostic du cancer
EP2262911A4 (fr) Compositions, procédé et trousses utilisant des sondes synthétiques pour déterminer la présence d'un acide nucléique voulu
EP3971299A3 (fr) Nécessaire ou dispositif de détection du cancer colorectal et méthode de détection associée
WO2010120853A3 (fr) Procédés et compositions visant à détecter et à différencier de petits arn dans un chemin de maturation d'arn
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP3967769A3 (fr) Kit ou dispositif de détection du cancer du poumon et procédé de détection
EP3816302A3 (fr) Kit ou dispositif de détection du cancer de l' sophage et procédé de détection
MX367666B (es) Composiciones y métodos para cuantificar una secuencia de ácido nucleico en una muestra.
MY170983A (en) Biomarker assays for detecting or measuring inhibition of tor kinase activity
HK1172931A1 (zh) 可用於檢測 突變的方法、引物、探針和試劑盒
BR112014020422A2 (pt) método para determinar a presença ou ausência de um polinucleotídeo alvo em uma amostra, oligonucleotídeo iniciador isolado ou partzime, duplex de ácido nucleico de cadeia dupla isolado, enzima de ácido nucleico multi-componente, complexo de ácido nucleico, uso da mnazyme e kit
EP2855708A4 (fr) Méthode de conception d'amorces, méthode de détection de polymorphismes mononucléotidiques (snp), méthode de distinction des snp, et amorces associées, oligonucléotides détectable, et kits
WO2013190071A3 (fr) Mesure simultanée de la génération de thrombine et de la force des caillots dans le plasma et le sang total
WO2013106844A3 (fr) Procédés et compositions pour le traitement et le diagnostic du cancer du pancréas
WO2012174378A3 (fr) Méthodes et matériaux permettant de déterminer un déséquilibre allélique
HK1176097A1 (en) Methods and reagent kits for determining the activity of thioredoxin reductase and the uses thereof
WO2012075069A3 (fr) Signatures et déterminants associés au cancer et leurs méthodes d'utilisation
EP2557156A4 (fr) AMORCE ET SONDE CONÇUES POUR DÉTECTER CHLAMYDIA TRACHOMATIS ET PROCÉDÉ DE DÉTECTION DE CHLAMYDIA TRACHOMATIS LES UTILISANT& xA;
MX340392B (es) Mutaciones del protooncogen de serina/treonina-proteina cinasa b-raf (braf) que confieren resistencia a los inhibidores del protooncogen de serina/treonina-proteina cinasa b-raf.
WO2012089753A3 (fr) Ensembles complexes de miarn en tant que biomarqueurs non invasifs pour glioblastome
WO2012164525A3 (fr) Biomarqueurs de vieillissement
AP2011005866A0 (en) Oligonucleotide probes and primers for detection of hepatitus B virus.
WO2013028544A3 (fr) Compositions et procédés de détection et de discrimination entre levure ou moisissure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12734748

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12734748

Country of ref document: EP

Kind code of ref document: A2